Showing results (1-10 of 14) with videos related to

Sort By:
Pageof 2
Lifetime Data Analysis|March 13, 2016
Sequential tests for non-proportional hazards dataMatthias Brückner, Werner Brannath
Statistics in Medicine|June 15, 2017
Estimation in multi-arm two-stage trials with treatment selection and time-to-event endpointMatthias Brückner, Andrew Titman, Thomas Jaki
Statistics in Medicine|September 8, 2018
Nonparametric adaptive enrichment designs using categorical surrogate dataMatthias Brückner, Hans U Burger, Werner Brannath
Methods of Information in Medicine|May 3, 2018
The Average Hazard Ratio - A Good Effect Measure for Time-to-event Endpoints when the Proportional Hazard Assumption is Violated?Geraldine Rauch, Werner Brannath, Matthias Brückner, et al.
Investigative Ophthalmology & Visual Science|November 8, 2012
Crystallin-β-b2-overexpressing NPCs support the survival of injured retinal ganglion cells and photoreceptors in ratsMichael R R Böhm, Sarah Pfrommer, Carolin Chiwitt, et al.
Cell Transplantation|October 10, 2014
βB2-Crystallin Promotes Axonal Regeneration in the Injured Optic Nerve in Adult RatsMichael R R Böhm, Verena Prokosch, Matthias Brückner, et al.
The British Journal of Dermatology|November 7, 2024
Artificial daylight photodynamic therapy using methyl aminolaevulinate in a real-world setting in Germany: results from the noninterventional study ArtLightWolfgang G Philipp-Dormston, Matthias Brückner, Matthias Hoffmann, et al.
Acta Dermato-Venereologica|April 23, 2025
Photoaging and Cosmetic Result with Artificial Daylight Photo-dynamic Therapy Using Methyl AminolevulinateRolf-Markus Szeimies, Matthias Brückner, Matthias Hoffmann, et al.
Molecular Psychiatry|June 24, 2018
New role of P2X7 receptor in an Alzheimer's disease mouse modelElodie Martin, Majid Amar, Carine Dalle, et al.
Pageof 2